Literature DB >> 12431636

Mechanisms of action of mycophenolate mofetil in preventing chronic rejection.

A C Allison1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12431636     DOI： 10.1016/s0041-1345(02)03538-8

Source DB:  PubMed          Journal:  Transplant Proc        ISSN： 0041-1345            Impact factor:   1.066


× No keyword cloud information.
  5 in total

Review 1.  2021 update on thyroid-associated ophthalmopathy.

Authors:  E J Neag; T J Smith
Journal:  J Endocrinol Invest       Date:  2021-08-20       Impact factor: 5.467

2.  Prospective, systematically recorded mycophenolate safety data in Graves' orbitopathy.

Authors:  M Riedl; A Kuhn; I Krämer; E Kolbe; G J Kahaly
Journal:  J Endocrinol Invest       Date:  2016-02-17       Impact factor: 4.256

3.  Alteration of the gut microbiome in mycophenolate-induced enteropathy: impacts on the profile of short-chain fatty acids in a mouse model.

Authors:  Manon Jardou; Quentin Provost; Clarisse Brossier; Émilie Pinault; François-Ludovic Sauvage; Roland Lawson
Journal:  BMC Pharmacol Toxicol       Date:  2021-10-28       Impact factor: 2.483

Review 4.  New insights into the pathogenesis and nonsurgical management of Graves orbitopathy.

Authors:  Peter N Taylor; Lei Zhang; George J Kahaly; Marian Ludgate; Richard W J Lee; Ilaria Muller; Daniel G Ezra; Colin M Dayan
Journal:  Nat Rev Endocrinol       Date:  2019-12-30       Impact factor: 43.330

Review 5.  Management of Graves Thyroidal and Extrathyroidal Disease: An Update.

Authors:  George J Kahaly
Journal:  J Clin Endocrinol Metab       Date:  2020-12-01       Impact factor: 5.958
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.